Case Report: Primary Hypothyroidism Associated With Lutetium 177-DOTATATE Therapy for Metastatic Paraganglioma

BACKGROUND: Lutetium 177 ((177)Lu) - DOTATATE is a form of peptide receptor radionuclide therapy (PRRT) utilized in the treatment of neuroendocrine tumors. Data on (177)Lu-DOTATATE-induced thyroid dysfunction is limited. CASE DESCRIPTION: A 29-year-old male with SDHB positive metastatic paragangliom...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Front Endocrinol (Lausanne)
Autores principales: Gubbi, Sriram, Al-Jundi, Mohammad, Del Rivero, Jaydira, Jha, Abhishek, Knue, Marianne, Zou, Joy, Turkbey, Baris, Carrasquillo, Jorge Amilcar, Lin, Emily, Pacak, Karel, Klubo-Gwiezdzinska, Joanna, Lin, Frank I-Kai
Formato: Artigo
Lenguaje:Inglês
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7859638/
https://ncbi.nlm.nih.gov/pubmed/33551992
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2020.587065
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares